Actively Recruiting
Phase 2 Study of MDMA-Assisted Therapy for Adjustment Disorder in Patients With Cancer and Their Close Supporters
Led by Sunstone Medical · Updated on 2026-05-04
20
Participants Needed
1
Research Sites
108 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of MDMA-assisted therapy to help patients with cancer and their close significant others cope with adjustment disorder AD. This phase 2 pilot trial involves 10 pairs dyads of patients and their concerned significant others, focusing on assessing the feasibility, tolerability, and early effectiveness of this treatment approach. This open-label, single-site study aims to improve both adjustment disorder symptoms and relationship functioning in these participants. The treatment includes two doses of MDMA given during an 8-week therapy period. Alongside the MDMA dosing, participants will engage in two preparatory sessions and four integrative sessions of non-drug therapy. The manualized therapy supports participants before, during, and after MDMA administration to ensure structured care throughout the treatment. Participants will be involved in assessments over the 8-week treatment period, with primary outcomes measuring effects on adjustment disorder and relationship functioning. Secondary outcomes include evaluations of psychological distress, mental adjustment to cancer, relationship quality, and health-related quality of life over a 24-week span. Sessions will be audio and video recorded, and participants must adhere to lifestyle modifications and medication requirements. Safety and tolerability will be closely monitored throughout the study.
CONDITIONS
Brief Title
MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other
Research Team
S
Study Contact
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here